betrixaban

Betrixaban: New Oral Blood Thinner Cleared by FDA

The U.S. Food and Drug Administration has granted Portola Pharmaceuticals permission to market …

Read the full story

Current News

Now Enrolling: C-TRACT Study

A new NIH-sponsored study – the Chronic Venous Thrombosis: Relief with Adjunctive Catheter-Directed Therapy study, or C-TRACT study – is…

APRIL E-NEWSLETTER | Welcome Spring

Spring has sprung, and that means longer days, more sunshine, and plenty of opportunities to get outside, get active, and…